InVivo Therapeutics receives patent NOA

The USPTO issues a Notice of Allowance (NOA) to InVivo Therapeutics Holdings (OTCQB:NVIV +1.2%) for its patent application No. 14/177,888 titled "Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries."

The application covers the company's Neuro-Spinal Scaffold and the scaffold combined with stem cells which is being developed for the treatment of chronic spinal cord injury.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs